Sleep duration and on time during different periods of the day and night in patients with advanced parkinson's disease receiving adjunctive ropinirole prolonged release

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Reichmann, Heinz ^a   Cooper, James ^b   Rolfe, Katie ^b   Martinez Martin, Pablo ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CATECHOL METHYLTRANSFERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA; ROPINIROLE; SELEGILINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG FORMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT SLEEP; PARKINSON DISEASE; PATIENT MONITORING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP WAKING CYCLE; SUSTAINED DRUG RELEASE; WAKEFULNESS;

EID: 79959213176     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/354760     Document Type: Article

References (21)

1. Tandberg E., Larsen J. P., Karlsen K., Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study Movement Disorders 1999 14 6 922 927
2. Karlsen K., Larsen J. P., Tandberg E., Jrgensen K., Fatigue in patients with Parkinson's disease Movement Disorders 1999 14 2 237 241 (Pubitemid 30011839)
3. Chaudhuri K. R., The basis for day and night-time control of symptoms of Parkinson's disease European Journal of Neurology 2002 9 supplement 3 40 43 (Pubitemid 35471982)
4. Martinez-Martin P., Schapira A. H. V., Stocchi F., Sethi K., Odin P., MacPhee G., Brown R. G., Naidu Y., Clayton L., Abe K., Tsuboi Y., MacMahon D., Barone P., Rabey M., Bonuccelli U., Forbes A., Breen K., Tluk S., Olanow C. W., Thomas S., Rye D., Hand A., Williams A. J., Ondo W., Chaudhuri K. R., Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients Movement Disorders 2007 22 11 1623 1629 (Pubitemid 47477925)
5. Damiano A. M., Snyder C., Strausser B., Willian M. K., A review of health-related quality-of-life concepts and measures for Parkinson's disease Quality of Life Research 1999 8 3 235 243 (Pubitemid 29367292)
6. Karlsen K. H., Tandberg E., Arsland D., Larsen J. P., Health related quality of life in Parkinson's disease: a prospective longitudinal study Journal of Neurology Neurosurgery and Psychiatry 2000 69 5 584 589
7. Shulman L. M., Taback R. L., Rabinstein A. A., Weiner W. J., Non-recognition of depression and other non-motor symptoms in Parkinson's disease Parkinsonism Related Disorders 2002 8 3 193 197 (Pubitemid 33091403)
8. Chaudhuri K. R., Yates L., Martinez-Martin P., The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential Current Neurology and Neuroscience Reports 2005 5 4 275 283 (Pubitemid 41149661)
9. Chaudhuri K. R., Logishetty K., Dopamine receptor agonists and sleep disturbances in Parkinson's disease Parkinsonism Related Disorders 2009 15 supplement 4 S101 S104
10. Frucht S., Rogers J. D., Greene P. E., Gordon M. F., Fahn S., Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole Neurology 1999 52 9 1908 1910 (Pubitemid 29260911)
11. Dhawan V., Healy D. G., Pal S., Chaudhuri K. R., Sleep-related problems of Parkinson's disease Age and Ageing 2006 35 3 220 228
12. Gjerstad M. D., Alves G., Wentzel-Larsen T., Aarsland D., Larsen J. P., Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006 67 5 853 858 (Pubitemid 44394202)
13. Comella C. L., Morrissey M., Janko K., Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy Neurology 2005 64 8 1450 1451 (Pubitemid 40570521)
14. Hgl B., Rothdach A., Wetter T. C., Trenkwalder C., The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease Neuropsychopharmacology 2003 28 10 1866 1870 (Pubitemid 41070852)
15. Tompson D. J., Vearer D., Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease Clinical Therapeutics 2007 29 12 2654 2666
16. Pahwa R., Stacy M. A., Factor S. A., Lyons K. E., Stocchi F., Hersh B. P., Elmer L. W., Truong D. D., Earl N. L., Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease Neurology 2007 68 14 1108 1115 (Pubitemid 46559844)
17. Stocchi F., Hersh B. P., Scott B. L., Nausieda P. A., Giorgi L., Bourgeois P., De Deyn P. P., Dom R., Jeanjean A., Roubcova D., Ruzicka E., Valis M., Deste A., Gil R., Viallet F., Csanyi A., Csiba L., Harcos P., Czopf J., Takcs A., Barone P., Nordera G., Onofri M., Drozdowski W., Kwiecinski H., Nyka W., Opala G., Szczudlik A., Boothman B., Burn D., Castleton B., Grosset D., Weiser R., Bernick C., Cohen S., Colcher A., Leopold N., Seeberger L., Stoven N., Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study Current Medical Research and Opinion 2008 24 10 2883 2895
18. Hersh B. P., Earl N. L., Hauser R. A., Stacy M., Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations Movement Disorders 2010 25 7 927 931
19. GlaxoSmithKline, Ropinirole XL prolonged-release tablets summary of product characteristics. February 2011, http://www.medicines.org.uk/emc/ medicine/20813/SPC/Requip+XL+prolonged-release+tablets/
20. Reimer J., Grabowski M., Lindvall O., Hagell P., Use and interpretation of on/off diaries in Parkinson's disease Journal of Neurology Neurosurgery and Psychiatry 2004 75 3 396 400 (Pubitemid 38338768)
21. Duek P., Bukov J., Rika E., Majerov V., Srp A., Jech R., Roth J., onka K., Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease Clinical Neuropharmacology 2010 33 4 186 190